FDA Guidance titled “Further Testing of Donations that are Reactive on a Licensed Donor Screening Test for Antibodies to Hepatitis C Virus; Guidance for Industry” was released on October 2, 2019 and recommends that CTS modify our current HCV reflex testing algorithm to support these best practices. The new algorithm will take effect on April 20, 2020.
Check out the Communication page for the complete details by clicking the link: Communications
The recent communication regarding the recent Anti-SARS-CoV-2 Total assay in Tampa has brought about...
CTS received notification from Sanochemia Pharmazeutika AG of their intent to immediately discontinu...
At CTS, we understand the impact converting to the Ortho viral marker platform has on your operation...
Just a reminder that the revised client forms implement today! Don't forget to toss your o...
As an organization dedicated to the safety of the world’s blood and plasma supply, Creative Testing...
CTS Charlotte Lab successfully implemented WNV NAT testing on the Panther Testing Platform on Monday...